CHRO (Chromocell) Bozor qiymatining balans qiymatiga nisbati
Chromocell Therapeutics (CHRO) ilg'or hujayralarni skriningidan foydalangan holda opioid bo'lmagan og'riq qoldiruvchi vositalarni ishlab chiqishda yetakchilik qilmoqda. GURU.Markets kunlik grafigidagi bozor qiymatining balans qiymatidan chetlashishi joriy -5.33 parametrini aks ettiradi. O'sish istiqbollari surunkali og'riqlar terapiyasi uchun narkotik bo'lmagan agentlarning tijoratlashtirilishiga asoslangan. Barqarorlik esa R&D laboratoriyalarining benuqson ishlashi va partiya ishlab chiqarish jadvaliga qat'iy rioya qilinishi bilan ta'minlanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CHRO_-_Chromocell-Therapeutics_-_Capitalization-to-Book-Value-Ratio "CHRO Chromocell Therapeutics Corp. Bozor kapitallashuvining balans qiymatiga nisbati (21.02.2024 - 02.07.2025) | 👁️GURU.Markets👁️")
Chromocell Therapeutics Corp (CHRO) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics Corporation|CHRO - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Chromocell Therapeutics Corporation
Kompaniyaning dastlabki tahlili:Chromocell Therapeutics, CHRO
Ushbu ko'rsatkich kompaniyaning sof aktivlarining bozor qayta baholanishini belgilaydi. Kapitalning nisbiy bozor bahosini tahlil qilish biznes qiymati dinamikasini uning balans qiymatiga nisbatan kuzatish imkonini beradi. Metrika bozor kapitalizatsiyasining kitob kapitaliga nisbati sifatida hisoblanadi. Grafikdagi pasayish tendentsiyasi operatsion marjalarning qisqarish xavfidan signal beradi. Chromocell Therapeutics (CHRO) uchun bu neyrobiologlarning elita xodimlariga va ilg'or infratuzilmaga kiritilgan investitsiyalar qiymatini aks ettiradi.
Raqobatchilar tahlili
Bozor qiymatining balans qiymatiga nisbati BIIB|NBIX (neurocrine.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AMLX|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com|Praxis Precision Medicines, Inc. (PRAX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati AVXL (Anavex)|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp|Prothena - Balans qiymatiga nisbatan bozor qiymati|ALEC (Alector Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga koeffitsiyenti|OMER (omeros.com) - Bozor qiymatining balans qiymatiga nisbati|NGNE (Neurogene Inc) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati ACIU (AC Immune Corp)|Bozor qiymatining balans qiymatiga koeffitsiyenti Voyager Corp|Bozor kapitallashuvining balans qiymatiga nisbati NMRA (Neumora Therapeutics)|Kapitallashuvning sof aktivlarga nisbati scilexholding.com (SCLX)|TVGN: Bozor kapitallashuvining balans qiymatiga nisbati|Alpha Cognition Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|CGTX - Bozor qiymatining balans qiymatiga nisbati|IKT: Bozor qiymatining balans qiymatiga nisbati|Cassava Sciences, Inc. (SAVA) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Assertio|COYA - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati VistaGen Therapeutics Inc (VTGN)|Kapitallashuvning sof aktivlarga nisbati Ovid Therapeutics Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori Acumen Pharmaceuticals, Inc (ABOS)|Bozor kapitallashuvining balans qiymatiga nisbati CervoMed Inc.|Balans qiymatiga nisbatan bozor qiymati Alterity Therapeutics Ltd. ATHE|CLNN (Clene Nanomedicine) - Bozor kapitallashuvining balans qiymatiga nisbati|PEPG: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Jupiter Neurosciences JUNS|Relmada Corp (RLMD) - Balans qiymatiga nisbatan bozor qiymati|ANVS (Annovis Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRCE|AIFF - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi anewmeds.com (KLTO)|NRSN: Bozor kapitallashuvining balans qiymatiga nisbati|RVPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|MetaVia, Inc. - Kapitallashuvning sof aktivlarga nisbati|neuraxis.com (NRXS) - Bozor kapitallashuvining balans qiymatiga nisbati|HSDT - Kapitallashuvning sof aktivlarga nisbati|Passage Bio (PASG) - Bozor kapitallashuvining balans qiymatiga multiplikatori|NEUP: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Minerva|Bozor kapitallashuvining balans qiymatiga nisbati ATHA (Athira Pharma, Inc.)|Kapitallashuvning sof aktivlarga nisbati ADXN (addextherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati ALZN|Balans qiymatiga nisbatan bozor kapitallashuvi Cyclerion Therapeutics Inc. CYCN|PTIX: Bozor kapitallashuvining balans qiymatiga nisbati|KTTA - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati cortigent.com CRGT|ATXI (avenuetx.com) - Balans qiymatiga nisbatan bozor qiymati|BCLI - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CARA|Eliem Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ITCI (intracellulartherapies.com)|LBPH - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati marinuspharma.com MRNS|NKGN (NKGen Biotech) - Bozor kapitallashuvining balans qiymatiga nisbati|NeuroBo Pharmaceuticals Inc (NRBO) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SAGE: Kapitallashuvning sof aktivlarga nisbati|SNPX (Synaptogenix, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|TRVN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati VIGL|Anew Medical, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cerevel Therapeutics Inc (CERE)